Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk
other	Constipation	Gastrointestinal disorders	Spesolimab 900 mg i.v. SD	1	11
other	Chest pain	General disorders	Spesolimab 900 mg i.v. SD	1	11
other	Face oedema	General disorders	Spesolimab 900 mg i.v. SD	1	11
other	Malaise	General disorders	Spesolimab 900 mg i.v. SD	1	11
other	Periodontitis	Infections and infestations	Spesolimab 900 mg i.v. SD	1	11
other	Wound	Injury, poisoning and procedural complications	Spesolimab 900 mg i.v. SD	1	11
other	Coronavirus test positive	Investigations	Spesolimab 900 mg i.v. SD	1	11
other	Transaminases increased	Investigations	Spesolimab 900 mg i.v. SD	1	11
other	Headache	Nervous system disorders	Spesolimab 900 mg i.v. SD	1	11
other	Pollakiuria	Renal and urinary disorders	Spesolimab 900 mg i.v. SD	1	11
other	Acne	Skin and subcutaneous tissue disorders	Spesolimab 900 mg i.v. SD	1	11
other	Pustular psoriasis	Skin and subcutaneous tissue disorders	Spesolimab 900 mg i.v. SD	2	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05200247/events